A01K2207/25 - CPC Classification Index

#1

20260139021

2026-05-21

VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR (FGF21) CODING SEQUENCE

#2

20250324953

2025-10-23

FEED COMPOSITION FOR CONSTRUCTION OF STEATOHEPATITIS ANIMAL MODEL

#3

20240206438

2024-06-27

SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF

#4

20240182534

2024-06-06

VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE

#5

20240108049

2024-04-04

METHOD FOR DIAGNOSIS OF NEURODEGENERATIVE DISEASES BY USING HPMA

#6

20230380461

2023-11-30

AQUACULTURED CRUSTACEAN AND METHOD OF PRODUCING SAME

#7

20230310513

2023-10-05

METHOD FOR FEEDING A FLATWORM AND FLATWORM EXTRACT FREE OF HUMAN-PATHOGENIC MICROORGANISMS

#8

20230309520

2023-10-05

AGE-RELATED HEARING LOSS ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR

#9

20220117206

2022-04-21

Mouse model of alcohol-induced liver cancer

#10

20210195875

2021-07-01

NON-HUMAN ANIMALS EXHIBITING DEGENERATIVE SYMPTOM ATTRIBUTED TO PROTEIN AGGREGATION

#11

20210127647

2021-05-06

Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease

#12

20210011004

2021-01-14

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#13

20200305467

2020-10-01

Method for improving immunity in shrimps

#14

20200221673

2020-07-16

Aquacultured crustacean and method of producing same

#15

20200188533

2020-06-18

DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN

#16

20200128801

2020-04-30

INFORMATION PROVIDING METHOD FOR DIAGNOSING PARKINSONS DISEASE

#17

20200102361

2020-04-02

VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE

#18

20190191676

2019-06-27

Use of C1q/TNF-related protein-1 (CTRP1) to treat fatty liver disease

#19

20190141966

2019-05-16

Non-Human Animals Comprising SLC30A8 Mutation And Methods Of Use

#20

20180369423

2018-12-27

Animal models for nonalcoholic fatty liver disease

#21

20180303075

2018-10-25

A MOUSE MODEL OF NONALCOHOLIC STEATOHEPATITIS AND USES THEREOF

#22

20180246081

2018-08-30

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#23

20180206461

2018-07-26

INHIBITING CTRP5 ACTION TO IMPROVE INSULIN RESISTANCE ASSOCIATED WITH OBESITY AND TYPE 2 DIABETES

#24

20180125042

2018-05-10

ANIMAL MODEL HAVING HYPOPARATHYROIDISM AND METHOD FOR PRODUCING THE SAME

#25

20160377598

2016-12-29

Methods for treating diet-induced obesity by decreasing or inhibiting P2Y2 purinergic receptor expression or activity

#26

20160360735

2016-12-15

Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics

#27

20150320769

2015-11-12

Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation

#28

20150296757

2015-10-22

Animal model for type 2 diabetes and obesity

#29

20150282461

2015-10-08

METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT

#30

20150272093

2015-10-01

Taste independent brain nutrient sensor that mediates hunger

#31

20150259692

2015-09-17

Composition and methods for the prevention and treatment of diet-induced obesity

#32

20150208620

2015-07-30

Obesity animal model and methods for making and using thereof

#33

20140314789

2014-10-23

Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors

#34

20140178306

2014-06-26

Steatohepatitis-liver cancer model animal

#35

20130061339

2013-03-07

METHOD OF DIAGNOSING TRICHOTILLOMANIA AND SIMILAR DISORDERS IN HUMANS AND RODENTS

#36

20120264816

2012-10-18

Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation

#37

20120117671

2012-05-10

STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL

#38

20110239318

2011-09-29

METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT

#39

20110152351

2011-06-23

Modulation of SMRT expression